CellWell record HH-591165
Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review
Marko Sever; Anita Zenko Sever; Robert Klicek; Lucija Kralj; Marta Popovic Dolic; Kresimir Luetic; Dinko Bekic; Zeljka Belosic Halle; Mario Sucic; Suncana Sikiric; Lidija Beketic Oreskovic; Antun Bacic; Sanja Strbe; Eva Staresinic; Sven Seiwerth; Predrag Sikiric; Alenka Boban Blagaic; Ivan Dobric; Mario Staresinic; Anita Skrtic
2026
In plain language
This narrative review reports that a gastric pentadecapeptide was associated with preventing and reversing experimentally induced portal hypertension and hepatic injury in animal models, but clinical efficacy remains unestablished.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-591165
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.